Gilead’s remdesivir, shown to hasten COVID-19 recovery, cleared for emergency use by FDA
The Food and Drug Administration on Friday cleared an experimental drug from Gilead for emergency use in treating COVID-19, acting quickly following announcement on Wednesday of encouraging results from a crucial government-run study. Results from the study, which was led by the National Institutes for Allergy and Infectious Diseases, showed treatment with remdesivir led to… Read More »